Muscle Relaxant Drugs Market Size : Global Industry Demand, Historical Growth, share & Forecast 2024

Text Size:

Muscle Relaxant Drugs Market Overview

Muscle relaxant drugs are used to reduce the pain caused by contraction of muscles, and hyperreflexia. These drugs are very suitable in those situations where spasms muscle causing low back pain. These muscle relaxants are a short term treatment of these muscle pains. A muscle relaxant drug depresses the central nervous system in order to reduce the muscle tones and affects the skeletal muscles. Further, muscle relaxant drugs are highly restricted to consume by pregnant women, old person and other drug or alcohol addicted persons.

Market Segmentation

Global muscle relaxant drugs market is projected to grow at a significant compound annual growth rate of 6.3% over the forecast period 2017-2024. Growing geriatric population and growing preference of drugs amongst the consumers are some major factors which are expected to foster the growth of global muscle relaxant drugs market during the forecast period.

On the basis of regional platform, global muscle relaxant drugs market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.CLICK TO DOWNLOAD FREE SAMPLE

Global market of muscle relaxant drugs is dominated by North America region. Moreover, large geriatric population and growing awareness amongst the consumers regarding the musculoskeletal problems are some major factors which are predicted to foster the growth of muscle relaxant drugs market in North America region. Large number of spa and salons in this region is a key factor which is likely to allow North America region to continue its dominance over the forecast period.

Further, Asia Pacific muscle relaxant drugs market is envisioned to grow at fastest pace during the forecast period. Factors such as growing geriatric population and rising number of surgeries are projected to bolster the growth of muscle relaxant drugs market in Asia Pacific region. China, India & Japan are likely to contribute significantly in growth of market owing to enhancement of health care infrastructure in these countries.

Additionally, Europe region is also anticipated to witness a satisfactory growth during the forecast period owing to high investment in research and development of health care infrastructure in this region.

By drugs type, market is segmented into facial asthenic relaxant drugs, skeletal muscle relaxant drugs and neuromuscular blocking agents. Neuromuscular blocking agents or drugs are representing highest demand in the global market and is anticipated to behold this positive demand during the forecast period.

Market Segmentation

Our-in depth analysis of the global muscle relaxant drugs market includes the following segments:

By Type

Facial Muscle Relaxant Drugs
Skeletal muscle Relaxant Drugs
Neuromuscular Blocking Agents

By Route of Administration

Oral
Topical
Parenteral

By Distribution Channel

Online Stores
Drug Stores
Hospitals
Clinics

By Region

Global muscle relaxant drugs market is further classified on the basis of region as follows:

North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis
Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis

Growth Drivers & Challenges

Global muscle relaxant drugs market is primarily driven by growing geriatric population coupled with rising prevalence of musculoskeletal problems with aged people.

Moreover, rising prevalence of musculoskeletal problems and growing awareness amongst the consumers regarding their treatment and management are expected to be the dynamic factors behind the growth of global market of muscle relaxant drugs. Furthermore, rising number of patients suffering from lower back pain is a major factor likely to drive the demand for muscle relaxant drugs in near future.

Additionally, rising investment in research and development for enhancement of healthcare infrastructure is also anticipated to foster the growth of global market. Growing disposable income of the consumers and high expenditure on health care is also a major factor escalating the demand for muscle relaxant drugs in near future.

Apart from this, growing skin related problems and increasing number of surgeries is also predicated to fuel the demand for muscle relaxant drugs. Further, growing use of muscle relaxant drugs during surgery as anesthesia is likely to drive the growth of global muscle relaxant drugs market.

However, muscle relaxant drugs are only used for short term treatment and also they do not treat underlying diseases or disorders. Such limitation of muscle relaxant drugs is a major challenge to the market which is expected to hamper the growth of global muscle relaxant drugs market in near future.

Key Players

Pfizer
- Company Overview
- Key Product Offerings
- Business Strategy
- SWOT Analysis
- Financials
Ipsen Group
Acorda Therapeutics
Allergan
Novartis
Teva Pharmaceuticals
Sanofi
Gedeon Richer Plc.
Medis Tunisia Pharmaceutical Laboratories
Glenmark Pharmaceuticals Ltd.